When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SPPI - Spectrum stock jumps 13% on commercial launch of Rolvedon
Spectrum Pharmaceuticals Inc.
Spectrum Pharmaceuticals ( NASDAQ: SPPI ) on Friday said that its medicine Rolvedon was now commercial available.
Rolvedon (eflapegrastim-xnst) injection was approved in the U.S. in September to decrease the incidence of infection, manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs linked with febrile neutropenia.
Neutropenia occurs when the body has fewer neutrophils, a type of white blood cell.